Resorcinol

Resorcinol

SCHEMBL4211332

Oc1cccc(O)c1.Oc1cccc(O)c1.c1cnnnc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.63
▸ ALDH1A1 P00352 3/20 0.63
▸ CA2 P00918 3/20 0.63
▸ CA9 Q16790 3/20 0.63
▸ CYP3A4 P08684 2/20 0.63
▸ CA14 Q9ULX7 2/20 0.63
▸ LMNA P02545 1/20 0.63
▸ CA5A P35218 1/20 0.63
▸ HSD17B10 Q99714 1/20 0.63
▸ CA5B Q9Y2D0 1/20 0.63
▸ HSD17B1 P14061 5/20 0.44
▸ HSD17B2 P37059 4/20 0.44
▸ TSHR P16473 2/20 0.44
▸ CA1 P00915 2/20 0.44
▸ ACHE P22303 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ LCK P06239 1/20 0.43
▸ ENPP2 Q13822 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resorcinol SCHEMBL1243197 1.00 CA12 (0.63) CA12ALDH1A1CA2CA9CYP3A4
Resorcinol SCHEMBL1244649 1.00 CA12 (0.63) CA12ALDH1A1CA2CA9CYP3A4
Phloroglucinol SCHEMBL29110699 0.86 BACE1 (0.50) CA12ALDH1A1CA2CA9CYP3A4
Resorcinol SCHEMBL7559136 0.82 TSHR (0.46) CA12ALDH1A1CA2CA9CYP3A4
Resorcinol SCHEMBL7561949 0.82 TSHR (0.46) CA12ALDH1A1CA2CA9CYP3A4
Phenol SCHEMBL5509919 0.81 CA12 (0.61) CA12ALDH1A1CA2CA9CYP3A4
Phenol SCHEMBL27969880 0.81 CA12 (0.61) CA12ALDH1A1CA2CA9CYP3A4
Phenol SCHEMBL723357 0.81 CA12 (0.61) CA12ALDH1A1CA2CA9CYP3A4
Resorcinol SCHEMBL326229 0.80 CA12 (1.00) CA12ALDH1A1CA2CA9CYP3A4
Resorcinol SCHEMBL15515 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116546962-A Skin care composition 莱雅公司 2023-08-04 — — CN claimed
CN-110831569-A Photoprotective composition comprising a dibenzoylmethane derivative, a merocyanine compound and a compound capable of accepting the energy of the triplet excitation level of the dibenzoylmethane compound 欧莱雅 2020-02-21 — — CN claimed
CN-114040747-B Oil-in-water type emulsified cosmetic 株式会社资生堂 2024-02-06 — — CN disclosed
US-7485723-B2 Process for making trisaryl triazine UV absorbers using Lewis acids and reaction promoters CYTEC TECHNOLOGY CORP. (US) 2009-02-03 — — US disclosed
US-20070015920-A1 Process for Making Trisaryl Triazine UV Absorbers Using Lewis Acids and Reaction Promoters GUPTA RAM B 2007-01-18 — — US disclosed
EP-1131305-B1 PROCESS FOR PREPARING TRIAZINES USING A COMBINATION OF LEWIS ACIDS WITH REACTION PROMOTERS CYTEC TECH CORP (US) 2006-11-02 — — EP disclosed
EP-1382599-B1 2-(2,4 dihydroxyphenyl)-4,6 bis(3,4-dimethylphenyl)-s-triazine and 2-(2,4-dihydroxyphenyl)4(3,4-dimethylphenyl)-6-(2,3-dimethylphenyl)-s-triazine and derivatives thereof as UV-absorber CYTEC TECH CORP (US) 2006-08-30 — — EP disclosed
US-20050165231-A1 Process for making triazine UV absorbers using Lewis acids and reaction promoters GUPTA RAM B (US) 2005-07-28 — — US disclosed
EP-1109792-B1 PROCESS FOR MAKING 2- (2,4- DIHYDROXYPHENYL) OR 2- (2,4- DIALKOXYPHENYL)- 4,6- BISARYL- 1,3,5- TRIAZINES CYTEC TECH CORP (US) 2005-07-27 — — EP disclosed
US-6900314-B2 Process for making triazine UV absorbers using lewis acids and reaction promoters CYTEC TECHNOLOGY CORP. (US) 2005-05-31 — — US disclosed
US-20040204585-A1 Process for making triazine UV absorbers using lewis acids and reaction promoters GUPTA RAM B (US) 2004-10-14 — — US disclosed
EP-1382599-A2 2-(2,4 dihydroxyphenyl)-4,6 bis(3,4-dimethylphenyl)-s-triazine and 2-(2,4-dihydroxyphenyl)4(3,4-dimethylphenyl)-6-(2,3-dimethylphenyl)-s-triazine and derivatives thereof as UV-absorber CYTEC TECHNOLOGY CORP. (US) 2004-01-21 — — EP disclosed
US-6486316-B1 Process for making triazine UV absorbers using Lewis acids and reaction promoters CYTEC TECHNOLOGY CORP. 2002-11-26 — — US disclosed
US-20020013463-A1 Process for making triazine UV absorbers using Lewis acids and reaction promoters CYTEC INDUSTRIES CORP. 2002-01-31 — — US disclosed
EP-1131305-A1 PROCESS FOR PREPARING TRIAZINES USING A COMBINATION OF LEWIS ACIDS WITH REACTION PROMOTERS CYTEC TECHNOLOGY CORP. (US) 2001-09-12 — — EP disclosed
US-20010020094-A1 Process for making triazine UV absorbers using lewis acids and reaction promoters CYTEC TECHNOLOGIES CORP. 2001-09-06 — — US disclosed
EP-1109792-A1 PROCESS FOR MAKING 2- (2,4- DIHYDROXYPHENYL) OR 2- (2,4- DIALKOXYPHENYL)- 4,6- BISARYL- 1,3,5- TRIAZINES CYTEC TECHNOLOGY CORP. (US) 2001-06-27 — — EP disclosed
US-6225468-B1 HEATING AND PRESSURIZING TRIHALO-1,3,5-TRIAZINE WITH PHENOL DERIVATIVE AND BENZENE DERIVATIVE TO IN PRESENCE OF CATALYST FORM ARYL SUBSTITUTED TRIAZINE COMPOUND CYTEC TECHNOLOGY CORP. 2001-05-01 — — US disclosed
WO-2000029392-A1 PROCESS FOR PREPARING TRIAZINES USING A COMBINATION OF LEWIS ACIDS AND REACTION PROMOTERS CYTEC TECHNOLOGY CORP. (US) 2000-05-25 — — WO disclosed
WO-2000014077-A1 PROCESS FOR MAKING 2- (2,4- DIHYDROXYPHENYL) OR 2- (2,4- DIALKOXYPHENYL)- 4,6- BISARYL- 1,3,5- TRIAZINES CYTEC TECHNOLOGY CORP. (US) 2000-03-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204585-A1 Process for making triazine UV absorbers using lewis acids and reaction promoters TYR, TDO2, CYP4Z1 CA12 276/4885ALDH1A1 375/4885CA2 388/4885
US-20020013463-A1 Process for making triazine UV absorbers using Lewis acids and reaction promoters TYR, TDO2, CYP4Z1 CA12 276/4885ALDH1A1 375/4885CA2 388/4885
US-20050165231-A1 Process for making triazine UV absorbers using Lewis acids and reaction promoters TYR, TDO2, CYP4Z1 CA12 276/4885ALDH1A1 375/4885CA2 388/4885
US-20070015920-A1 Process for Making Trisaryl Triazine UV Absorbers Using Lewis Acids and Reaction Promoters TYR, TDO2, CYP4Z1 CA12 330/4885ALDH1A1 391/4885CA2 417/4885
US-20010020094-A1 Process for making triazine UV absorbers using lewis acids and reaction promoters TYR, TDO2, CYP4Z1 CA12 276/4885ALDH1A1 375/4885CA2 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback